When Taylor Swift fans found out Lily Tomlinson was dying from a rare and aggressive brain tumor, they stepped up to comfort ...

Patricia Clarkson plays equal pay activist Lilly Ledbetter in the first trailer for 'Lilly.' Thomas Sadoski and John Benjamin Hickey also star in the movie, in theaters May 9.

Michigan softball catcher Lilly Vallimont has overcome her fair share of roadblocks on her softball journey, and is dedicated ...

In the wild world of celebrity love stories, we’ve seen it all, on-again, off-again romances, whirlwind weddings, and shocking splits. But the latest gossip bombshell? Lily Allen reportedly discovered ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self Pay Journey Program. The company said ...

Lily-Rose Depp channeled the gothic vibe of her ... back in 1953 to the 'How to Marry a Millionaire' premiere...I also love the special embroidery and detailing, it’s so beautiful." ...

Lily Collins shared a selfie capturing her baby daughter Tove's first beach day on Instagram on March 2. Collins and her husband, Charlie McDowell, welcomed Tove via surrogate in January 2025.

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

Magnet Biomedicine announced Friday it has reached a licensing agreement worth up to $1.25B with Eli Lilly (NYSE:LLY) to develop cancer drugs leveraging the company’s TrueGlue discovery platform.

Once again, Eli Lilly is using Hollywood’s biggest night as a platform to speak out on a hot-button issue in pharma. Throughout last year’s entertainment awards season, Lilly took aim at the ...

Lilly inked a deal in 2021 with exactly that protein-destroying goal in mind, promising potentially more than $1.6 billion to Lycia Therapeutics to find molecular glues for difficult targets in ...